{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:26:09Z","timestamp":1790727969796,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1I1A3A0106372612"],"award-info":[{"award-number":["2019R1I1A3A0106372612"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Alcohol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.alcohol.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T18:09:23Z","timestamp":1634926163000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7860-4539","authenticated-orcid":false,"given":"Ailyn","family":"Fadriquela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-9990","authenticated-orcid":false,"given":"Cheol-Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunological Reviews"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.4RU1016-450R","article-title":"Alcohol, aging, and innate immunity","volume":"102","author":"Boule","year":"2017","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.alcohol.2021.10.002_bib3","doi-asserted-by":"crossref","first-page":"3646975","DOI":"10.1155\/2019\/3646975","article-title":"Noninvasive indirect markers of liver fibrosis in alcoholics","volume":"2019","author":"Chrostek","year":"2019","journal-title":"BioMed Research International"},{"issue":"7","key":"10.1016\/j.alcohol.2021.10.002_bib4","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.00006-15","article-title":"Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression","volume":"89","author":"Clayton","year":"2015","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.alcohol.2021.10.002_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1016\/j.alcohol.2021.10.002_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/jcm7120542","article-title":"Effect of gender on the outcome of patients receiving immune checkpoint inhibitors for advanced cancer: A systematic review and meta-analysis of phase III randomized clinical trials","volume":"7","author":"Grassadonia","year":"2018","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40425-018-0449-0","article-title":"Soluble immune checkpoints in cancer: Production, function and biological significance","volume":"6","author":"Gu","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"9","key":"10.1016\/j.alcohol.2021.10.002_bib8","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/j.alcohol.2021.10.002_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20090397","article-title":"Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion","volume":"207","author":"Huang","year":"2010","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.alcohol.2021.10.002_bib10","series-title":"Paper presented at the mayo clinic proceedings","article-title":"Sex differences in alcohol consumption and alcohol-associated liver disease","author":"Kezer","year":"2021"},{"issue":"10","key":"10.1016\/j.alcohol.2021.10.002_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00308-2","article-title":"Storm of soluble immune checkpoints associated with disease severity of COVID-19","volume":"5","author":"Kong","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.alcohol.2021.10.002_bib13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fimmu.2019.01328","article-title":"Recent insights into the role of immune cells in mediating inflammation of alcoholic liver disease","volume":"10","author":"Li","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.alcohol.2021.10.002_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep4.1475","article-title":"Immune checkpoint Axes are dysregulated in patients with alcoholic hepatitis","volume":"4","author":"Li","year":"2020","journal-title":"Hepatology Communications"},{"issue":"2","key":"10.1016\/j.alcohol.2021.10.002_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.alcohol.2021.10.002_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology"},{"issue":"48","key":"10.1016\/j.alcohol.2021.10.002_bib17","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A\u00a0disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)","volume":"288","author":"M\u00f6ller-Hackbarth","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.alcohol.2021.10.002_bib18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3389\/fimmu.2019.01888","article-title":"Different expression characteristics of LAG3 and PD-1 in sepsis and their synergistic effect on T cell exhaustion: A new strategy for immune checkpoint blockade","volume":"10","author":"Niu","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.alcohol.2021.10.002_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: Pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Research"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-5926-11-5","article-title":"Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease","volume":"11","author":"Parkes","year":"2012","journal-title":"Comparative Hepatology"},{"issue":"2","key":"10.1016\/j.alcohol.2021.10.002_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.35946\/arcr.v37.2.04","article-title":"Impact of alcohol abuse on the adaptive immune system","volume":"37","author":"Pasala","year":"2015","journal-title":"Alcohol Research"},{"key":"10.1016\/j.alcohol.2021.10.002_bib22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: Reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-020-00947-6","article-title":"Targeting immune checkpoints in hematological malignancies","volume":"13","author":"Salik","year":"2020","journal-title":"Journal of Hematology & Oncology"},{"issue":"4","key":"10.1016\/j.alcohol.2021.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13296","article-title":"Soluble immune checkpoints CTLA-4, HLA-G, PD-1, and PD-L1 are associated with endometriosis-related infertility","volume":"84","author":"Santoso","year":"2020","journal-title":"American Journal of Reproductive Immunology"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nature Reviews. Disease Primers"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s40425-019-0810-y","article-title":"Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients","volume":"7","author":"Wang","year":"2019","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"3","key":"10.1016\/j.alcohol.2021.10.002_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.alcohol.2021.10.002_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005275","article-title":"Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent","volume":"96","author":"Ye","year":"2017","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.alcohol.2021.10.002_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12825","article-title":"TIM-3: An emerging target in the liver diseases","volume":"91","author":"Zhao","year":"2020","journal-title":"Scandinavian Journal of Immunology"}],"container-title":["Alcohol"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832921001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832921001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:49:01Z","timestamp":1760042941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741832921001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"alternative-id":["S0741832921001324"],"URL":"https:\/\/doi.org\/10.1016\/j.alcohol.2021.10.002","relation":{},"ISSN":["0741-8329"],"issn-type":[{"value":"0741-8329","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Alcohol","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alcohol.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}